Business, energy, technology, markets and global industry news from Business News Today

triglycerides

PharmaDeviceNews triglycerides
Representative image of a clinical researcher reviewing liver imaging and lipid test results, reflecting OrsoBio’s TLC-2716 Phase 2a data in severe hypertriglyceridemia and MASLD.
Pharma & Biotech

OrsoBio’s TLC-2716 data point to a new oral route in severe metabolic lipid disease

Find out how OrsoBio’s TLC-2716 Phase 2a data could reshape severe hypertriglyceridemia and MASLD drug development.

Read More
Representative image: Scientists analyze CRISPR gene-editing and liver-targeted cardiometabolic research data in a biotech laboratory, reflecting Scribe Therapeutics’ push to advance epigenetic silencing for durable LDL-C reduction.
Pharma & Biotech

Scribe Therapeutics brings specificity challenge into focus for CRISPR cardiometabolic drugs

CRISPR can lower cholesterol. The harder test is whether Scribe can make durability, precision, and scalability work in common disease.

Read More
Pharma & Biotech

Arrowhead’s plozasiran clears CHMP: what a positive opinion for FCS means for siRNA’s regulatory arc in Europe

Plozasiran clears CHMP but the real test is reimbursement. Europe's HTA bodies will now decide whether clinical FCS diagnosis is enough.

Read More